Portfolio company
Glyphic Biotechnologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
7 investors
Sectors
About
This company develops a single-molecule protein sequencing platform for researchers and institutions focused on biological research and drug discovery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Glyphic
This biotechnology company develops a protein sequencing platform for researchers to accelerate drug discovery and proteomic analysis.
Glyphic Bio
This company develops a single-molecule protein sequencing platform for researchers to identify amino acids and post-translational modifications in the human proteome.
Portal Biotech
The company develops nanopore-based instruments for single-molecule protein sequencing to serve researchers in drug discovery, diagnostics and biosecurity sectors.
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
DeepSeq.AI
DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.
Zephyrus Biosciences
This company develops single-cell protein analysis instruments and research tools for academic, biopharmaceutical and clinical scientists conducting disease research.
Ultima Genomics
This company develops and manufactures high-throughput DNA sequencing platforms for researchers and clinicians performing population-scale genomic analysis.
Single Cell Discoveries
This company provides single-cell sequencing and spatial transcriptomics services to pharmaceutical, biotechnology and academic organisations to support drug discovery and biological research.
